Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00602420 | Prevention of Pegfilgrastim-Induced Bone Pain (PIBP) | completed | Phase 3 | 510 | Gary MorrowOTHER | 1 | Nov 9, 2015 | clinicaltrials |
| NCT02056392 | To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | completed | Phase 1 | 54 | AstraZenecaINDUSTRY | 1 | Nov 9, 2015 | clinicaltrials |
| NCT00547547 |
| High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer |
| completed |
| Phase 1 |
| 22 |
| City of Hope Medical CenterOTHER |
| 1 |
| Nov 6, 2015 |
| clinicaltrials |
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00877474 | Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | PharmaMarINDUSTRY | 2 | Nov 4, 2015 | clinicaltrials |
| NCT01245543 | Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Daiichi SankyoINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT01299636 | Study of PM060184 in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | PharmaMarINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT01293630 | A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00704938 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer | terminated | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00932126 | This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors | terminated | Phase 1 | 35 | PfizerINDUSTRY | 2 | Oct 28, 2015 | clinicaltrials |
| NCT00890435 | Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | completed | — | 53 | Children's Oncology GroupNETWORK | 0 | Oct 21, 2015 | clinicaltrials |
| NCT01625156 | Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery | completed | Phase 1 | 11 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00557856 | A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | PfizerINDUSTRY | 3 | Oct 19, 2015 | clinicaltrials |
| NCT01100931 | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | completed | Phase 1 / Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2015 | clinicaltrials |
| NCT01128998 | Sorafenib Plus S-1 in Advanced Solid Tumors | completed | Phase 1 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00003817 | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | completed | Phase 2 | 700 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00020657 | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | completed | Phase 3 | — | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00042848 | Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 837 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00360867 | An Open Label Treatment Extension Study of AMG 706 | terminated | Phase 2 | 94 | AmgenINDUSTRY | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT00550017 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) | terminated | Phase 1 / Phase 2 | 39 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00255697 | Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers | completed | — | 863 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00884676 | Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 36 | Jaime MerchanOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00093678 | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer | withdrawn | N/A | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Genentech, Inc.INDUSTRY | 0 | Oct 8, 2015 | clinicaltrials |
| NCT02462707 | A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Oct 7, 2015 | clinicaltrials |
| NCT01039155 | Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01548482 | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00770536 | AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR | completed | Phase 1 | 103 | AmgenINDUSTRY | 3 | Sep 29, 2015 | clinicaltrials |
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | terminated | Phase 3 | 210 | National Cancer Centre, SingaporeOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01317927 | A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies | completed | Phase 1 | 27 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02525536 | A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors | completed | Phase 1 | 18 | TakedaINDUSTRY | 0 | Sep 22, 2015 | clinicaltrials |
| NCT01501604 | BKM120 in Cancers With PIK3CA Activating Mutations | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 0 | Sep 17, 2015 | clinicaltrials |
| NCT01560325 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 21 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Sep 16, 2015 | clinicaltrials |
| NCT00598091 | A Phase I/Expansion Study of Dasatinib(Gem/Dsat) | terminated | Phase 1 | 30 | Duke UniversityOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT01071018 | A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007) | completed | Phase 1 | 24 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 7, 2015 | clinicaltrials |
| NCT02263950 | A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours(LON002-002) | unknown | Phase 1 / Phase 2 | 87 | LondonPharma Ltd.INDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 2 | Sep 1, 2015 | clinicaltrials |
| NCT01383473 | Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients | completed | — | 14 | St. Jude Children's Research HospitalOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT01553656 | Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer | completed | Phase 1 | 85 | ExelixisINDUSTRY | 1 | Aug 20, 2015 | clinicaltrials |
| NCT02395068 | Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors | unknown | Phase 1 | 40 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02300467 | NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors | unknown | Phase 1 | 30 | National OncoVentureOTHER | 1 | Aug 14, 2015 | clinicaltrials |
| NCT01362985 | Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor | completed | — | 201 | Genzyme, a Sanofi CompanyINDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT00022165 | Selenium in the Prevention of Cancer | completed | N/A | 501 | University of SurreyOTHER | 1 | Aug 11, 2015 | clinicaltrials |
| NCT01574235 | Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents | completed | — | 2,114 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01627990 | Nivestim™ in Treatment of Malignant Diseases | completed | — | 386 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 24, 2015 | clinicaltrials |
| NCT00121277 | Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 28 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00126620 | Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 17 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01163903 | Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours | completed | Phase 1 | 24 | University Health Network, TorontoOTHER | 1 | Jul 15, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Nov 9, 2015source: clinicaltrials